Yongin, South Korea

Min Sun Lee

This inventor holds 1 USPTO granted patent. Top assignee: Sk Chemicals Co., Ltd.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Min Sun Lee. Retrieved from https://idiyas.com/inventor/min-sun-lee-jgl5xu9j

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Min Sun Lee: Innovator in Blood Coagulation Research

Introduction

Min Sun Lee is a prominent inventor based in Yongin-si, South Korea. She has made significant contributions to the field of blood coagulation through her innovative research and development. Her work focuses on improving treatments for conditions associated with factor IX deficiency.

Latest Patents

Min Sun Lee holds a patent for a fusion protein having factor IX activity. This fusion protein comprises blood coagulation factor IX (FIX) and transferrin. The invention demonstrates improved specific FIX activity compared to native FIX, making it a potential therapeutic option for treating FIX deficiency-associated diseases.

Career Highlights

Min Sun Lee is affiliated with SK Chemicals Co., Ltd., where she continues to advance her research in blood coagulation. Her dedication to innovation has positioned her as a key figure in her field.

Collaborations

Throughout her career, Min Sun Lee has collaborated with notable colleagues, including Hun-Taek Kim and Bong-Yong Lee. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking solutions in medical science.

Conclusion

Min Sun Lee's contributions to blood coagulation research exemplify the impact of innovative thinking in medicine. Her work not only advances scientific knowledge but also holds promise for improving patient outcomes in the treatment of blood coagulation disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…